# Characterization of Non‐Specific Electrostatic Interactions of Cationic Peptides with DNA Origami and Their Functional Consequences

**Authors:** Seung Hyun Kang, Oheun Kwon, Bo Kyung Cho, Seungmin Yoo, Jin Myeong Wang, Youngjin Choi, Hong Yeol Yoon, Jungkyu Choi, Ju Hee Ryu

PMC · DOI: 10.1002/smtd.202501936 · Small Methods · 2025-12-05

## TL;DR

This study shows how cationic peptides stick too much to DNA nanostructures and how to fix it for better nanodevices.

## Contribution

A charge-dependent purification strategy using PEG is introduced to control peptide binding on DNA origami.

## Key findings

- Cationic peptides bind non-specifically to DNA origami in large excess.
- PEG purification effectively reduces non-specific binding, with cationic peptides needing more cycles.
- Only site-specifically attached therapeutic peptides show biological activity.

## Abstract

The functionalization of DNA origami with peptides is a powerful strategy for creating nanodevices for therapeutic and diagnostic applications. A critical but often overlooked challenge is the non‐specific electrostatic binding of cationic peptides to the anionic DNA nanostructure, which leads to uncontrolled stoichiometry and undermines functional predictability. Here, the study systematically characterizes this issue and demonstrates a practical purification strategy to mitigate it. It is quantitatively shown that cationic peptides associate with DNA origami in vast excess of their intended binding sites, a phenomenon not observed with anionic control peptides. This non‐specific binding is confirmed to be electrostatic and is effectively screened by high salt. To address this, a charge‐dependent purification approach is evaluated using polyethylene glycol (PEG) precipitation, showing that cationic peptides require extensive purification (≥7 cycles), whereas anionic peptides need only minimal treatment (2 cycles) to achieve precise loading. Crucially, the study provides definitive functional evidence that a therapeutic peptide (brain‐derived neurotrophic factor‐mimicking peptide) must be attached via stable, site‐specific hybridization to elicit a potent biological response; non‐specifically adsorbed peptides are largely inactive. This work provides a set of critical design guidelines and purification considerations necessary for the rational design of reliable and functionally predictable DNA nanodevices.

DNA origami offers a precise platform for peptide functionalization, but its negatively charged scaffold causes severe non‐specific adsorption of cationic peptides. This study systematically quantifies this electrostatic artifact and introduces a charge‐tailored polyethylene glycol (PEG) purification workflow that restores stoichiometric control. The authors further demonstrate that only site‐specifically hybridized therapeutic peptides retain biological activity, guiding reproducible functional DNA nanodevice design.

## Linked entities

- **Chemicals:** polyethylene glycol (PubChem CID 9033), PEG (PubChem CID 174)

## Full-text entities

- **Genes:** BDNF (brain derived neurotrophic factor) [NCBI Gene 627] {aka ANON2, BULN2}
- **Chemicals:** PEG (MESH:D011092), salt (MESH:D012492)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12790360/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12790360/full.md

## References

59 references — full list in the complete paper: https://tomesphere.com/paper/PMC12790360/full.md

---
Source: https://tomesphere.com/paper/PMC12790360